Keyphrases
Indonesia
100%
Surabaya
53%
COVID-19
46%
Helicobacter Pylori (H. pylori)
36%
AIDS/HIV
30%
Type 2 Diabetes Mellitus (T2DM)
22%
Helicobacter Pylori Infection
20%
Indonesian
19%
Human Immunodeficiency Virus Type 1 (HIV-1)
19%
Chronic Kidney Disease
19%
Meta-analysis
17%
Type 2 Diabetic Patients
16%
Type 1 Diabetes Mellitus (T1DM)
14%
Chronic Kidney Disease Patients
14%
Systematic Meta-analysis
13%
Antiretroviral Therapy
12%
Risk Factors
12%
Hemodialysis
11%
General Hospital
10%
HIV Patients
10%
COVID-19 Patients
10%
Hypertension
9%
Systemic Lupus Erythematosus
9%
AIDS Patients
9%
Interleukin-6
9%
Type 2 Diabetes Mellitus Patients
8%
Antibiotics
8%
CRF01_AE
8%
Disease Activity
8%
CagA
7%
Hemoglobin A1c (HbA1c)
7%
Gastric Cancer
7%
Drug Resistance mutations
7%
East Java Indonesia
7%
Medical Records
7%
Hemodialysis Patients
7%
D-dimer
7%
Glycemic Control
7%
Non-dialysis Chronic Kidney Disease
6%
Indonesian Population
6%
Insulin Resistance
6%
Inflammation
6%
Frailty
6%
COVID-19 Pandemic
6%
Comorbidity
6%
Obesity
6%
Body Mass Index
6%
Nave
6%
Clinical Manifestations
6%
Sarcopenia
6%
Human Immunodeficiency Virus/acquired Immunodeficiency Syndrome
5%
Sepsis
5%
Referral Hospital
5%
Patients with Diabetes Mellitus
5%
Pulmonary Tuberculosis
5%
High Prevalence
5%
Confidence Interval
5%
Healthcare Workers
5%
Fever
5%
Tuberculosis
5%
Odds Ratio
5%
Oxidative Stress
5%
Hepatitis B Virus
5%
Ethyl Acetate
5%
Psoriatic Arthritis
5%
Genotype
5%
Escherichia Coli
5%
Antibiotic Resistance
5%
Intact Parathyroid Hormone (iPTH)
5%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
49%
HIV
34%
Infection
30%
Helicobacter Pylori
28%
Prevalence
24%
Coronavirinae
24%
Non Insulin Dependent Diabetes Mellitus
22%
Chronic Kidney Failure
19%
Hemodialysis
19%
Diabetes Mellitus
19%
Cross-Sectional Study
13%
Drug Resistance
9%
Inflammation
9%
C Reactive Protein
9%
Comorbidity
8%
Antibiotics
8%
SARS Coronavirus
8%
Retrospective Study
8%
Antimicrobial Resistance
8%
Helicobacter Infection
7%
Hemoglobin A1c
7%
Human Immunodeficiency Virus 1
7%
Interleukin 6
7%
Sepsis
6%
Disease Activity
6%
Clarithromycin
6%
Dengue Virus
6%
Metronidazole
6%
Sarcopenia
6%
Dengue
6%
D Dimer
6%
Frailty
5%
Abdominal Cancer
5%
Virus Infection
5%
Systemic Lupus Erythematosus
5%
Biological Marker
5%
Hepatitis B Virus
5%
Acquired Immune Deficiency Syndrome
5%
Medicine and Dentistry
COVID-19
40%
Infection
23%
Helicobacter Pylori
22%
Diabetes Mellitus
19%
Diseases
17%
Human Immunodeficiency Virus
16%
Chronic Kidney Disease
16%
Prevalence
15%
Systematic Review
14%
Maturity Onset Diabetes of the Young
12%
Diagnosis
11%
Meta-Analysis
10%
Cross Sectional Study
9%
Hemodialysis
9%
Diabetes
7%
Retrospective Study
6%
Lymphocyte
6%
Patient with Diabetes
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Human Immunodeficiency Virus 1
6%
Case Presentation
6%
Abdominal Cancer
6%
Helicobacter Infection
6%
Comorbidity
5%
Antiretroviral Therapy
5%
HIV/AIDS
5%
Systemic Lupus Erythematosus
5%
Drug Resistance
5%